Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vaxfab Enterprises held its Annual General Meeting on September 30, 2025, at its registered office in Ahmedabad. Five resolutions were tabled and all were passed unanimously with 100% votes in favour (20 members representing 20,58,441 shares, zero votes against). The resolutions included adoption of the audited standalone financial statements for FY ended March 31, 2025, reappointment of Mr. Nishant Subhashchandra Gandhi (DIN: 09250907) as a director retiring by rotation, and ratification of M/s. A. Shubhangi and Associates as secretarial auditors. Two special resolutions were also cleared: an increase in the authorised share capital with a corresponding amendment to the capital clause of the Memorandum of Association, and the issuance of fully convertible warrants on a preferential issue basis.
Shareholders should note that the cleared increase in authorised share capital and approval to issue fully convertible warrants on a preferential basis open the door for potential equity dilution and capital raising, though no immediate dilution is implied until the warrants are actually allotted. The unanimous approval on all items signals strong shareholder backing for the management's plans.